Top N.C. Cancer Experts to Discuss Critical Need of Increasing Patient Access to Clinical Trials at Event Hosted by Nation’s Leading Cancer Advocacy Group

State leaders in medicine, research and government to lead Nov. 12 panel

November 7, 2019
RALEIGH, N.C.—North Carolina’s American Cancer Society Cancer Action Network (ACS CAN) 10th annual research breakfast will focus on the current state of clinical trials in North Carolina and overcoming the patient enrollment barriers which currently exist.
Fact: This year alone, the American Cancer Society estimates that nearly 60,000 people in North Carolina will be diagnosed with cancer and more than 20,000 will die from the disease.
WHAT: ‘Increasing Access to Care Through Clinical Trials: Potential Problems and Promising Practices’
The event will bring together key thought leaders and subject matter experts in medicine, research and government and aims to raise awareness amongst North Carolina legislators about the critical role clinical trials play in cancer research and patient survivorship. Yet currently in the U.S.:
- 55% of cancer patients do not have access to a clinical trial where they are seeking treatment, and another 17% will not meet eligibility requirements.
- 20% of cancer clinical trials fail due to insufficient patient enrollment.
The forum is closely tied to ACS CAN’s federal initiative on increasing access to cancer care.
- Penny Lauricella, vice chair, American Cancer Society Central & Eastern North Carolina Board of Directors.
- Dr. Steven Patierno, deputy director, Duke Cancer Institute.
- Chloe Fournier, associate director of compliance and training at Duke Cancer Institute.
- Dr. Marjory Charlot, assistant director, community outreach & patient engagement research, University of North Carolina Lineberger Comprehensive Clinical Cancer Center.
- Dr. Karen Winkfield, director, Office of Cancer Health Equity & associate director for Community Outreach & Engagement, associate professor of radiation oncology, Wake Forest Baptist Health Comprehensive Cancer Center.
- Patrick Nealon, executive vice president and general manager of oncology, Syneos Health.
- Rep. Wayne Sasser (R-67), N.C. House of Representatives.
- Devora Ascott Black, cancer patient & clinical trial participant.

WHEN: Tuesday, Nov. 12, 2019, 7-9 a.m.
WHERE: North Carolina Museum of History, 5 East Edenton St., Raleigh, NC 27601
HOW: To attend, please contact Vanessa Hill at [email protected] or 336-202-5266.
The American Cancer Society Cancer Action Network (ACS CAN) is making cancer a top priority for public officials and candidates at the federal, state and local levels. ACS CAN empowers advocates across the country to make their voices heard and influence evidence-based public policy change as well as legislative and regulatory solutions that will reduce the cancer burden. As the American Cancer Society’s nonprofit, nonpartisan advocacy affiliate, ACS CAN is critical to the fight for a world without cancer. For more information, visit
More Press Releases AboutAccess to Health Care, North Carolina

Media Contacts

Vanessa Hill
Media Advocacy Manager
Raleigh, NC